C5's 11th Pharma & Biotech Patent Litigation Conference

26/02/2019

GO

C5’s 11th Annual Pharma and Biotech Patent Litigation Forum comes at a significant time in Europe. With Brexit looming and the impending ratification of UPC from the German national courts, there are plenty of uncertainties for Pharmaceutical and Biotech companies conducting business in the European Market. This event is where you will find clarification on such matters and their consequential impact on patent litigation strategies.

Bristows' Dominic Adair will be speaking at 11:15am on 27 February on "Digital Concerns for the Quality of Patents"

What is it about?

The digital era has brought a considerable amount of data to the field of patenting. This poses a real concern to innovators as how to best protect their products. Join us for a fireside chat with distinguished outside and in-house counsel as they discuss:

  • How the digital age is affecting the quality of patent
  • More data: can this create different types of claim?
  • Whether an increase data can provide better claims?
  • Creating insights for new ways in producing different results
  • What are the consequences with access to more data.

Please find more information about this conference here 


08:00am
09:00am
5:00pm day one, 4:30pm day two

Amsterdam

C5’s 11th Annual Pharma and Biotech Patent Litigation Forum comes at a significant time in Europe. With Brexit looming and the impending ratification of UPC from the German national courts, there are plenty of uncertainties for Pharmaceutical and Biotech companies conducting business in the European Market. This event is where you will find clarification on such matters and their consequential impact on patent litigation strategies.
Back to Events